[1] Naylor A. Intervertebral disc prolapse and degeneration: The biomechanical and biophysical approach. Spine. 1976; 1(2): 108–114.
[[2] Powell MC, Wilson M, Szypryt S, Symonds EM. Prevalence of lumbar disc degeneration observed by magnetic resonance in symptomless women. The Lancet. 1986 Dec 13; 328(8520): 1366–1367.
[3] Ombregt L. A System of Orthopaedic Medicine. 3rd ed. London, England: Churchill Livingstone Elsevier, 2013.
[4] Hackett GS, Hemwall GA, Montgomery GA. Ligament and Tendon Relaxation Treated by Prolotherapy. 5th ed. (p. 9), commenting on work of Newman PH). Oak Brook, Illinois: Institute in Basic Life Principles, 1991.
[5] Acarpglu ER, Iatridis JC, Setton LA, Foster RJ, Mow VC, Weidenbaum M. Degeneration and aging affect the tensile behavior of human lumbar annulus fibrosus. Spine. 1995; 20(24): 2690–2701.
[6] Krag MH, Seroussi RE, Wilder DG, Pope MH. Thoracic and lumbar internal disc displacement distribution from in vitro loading of human spinal motion segments: Experimental results and theoretical predictions. Spine. 1987; 12: 1001–1007; Ombregt, L. A System of Orthopaedic Medicine. 3rd ed., London, England: Churchill Livingstone Elsevier, 2013.
[7] Ombregt, L. A System of Orthopaedic Medicine. 3rd ed. London, England: Churchill Livingstone Elsevier, 2013.
[8] Nachemson A. Advances in low back pain. Clinical Orthopaedics and Related Research. 1985 Nov 1; 200: 266-278; Paster RZ. Nonpharmacologic management of low back pain. Family Practice Recertification Management of Chronic Low Back Pain Special Supplement. 1999 Jun; 21(7): 6–9.
[9] Buschbacher R. Practical Guide to Musculoskeletal Disorders: Diagnosis and Rehabilitation, 2nd ed. (p. 100). Boston, Massachusetts: Butterworth Heinemann, 2002; Cyriax JH. Illustrated Manual of Orthopaedic Medicine, 2nd ed. (p. 199). Oxford, England: Butterworth-Heineman, 1998.
[10] Hakelius A. Prognosis in sciatica: A clinical follow-up of surgical and nonsurgical treatment. Acta Orthopaedica Scandinavica. 1970; 41(Sup 129): 1–16; Nashold BS, Hrubec Z. Lumbar Disc Disease: A Twenty-Year Clinical Follow-Up Study. St. Louis, Missouri: Mosby, 1971.
[11] Alaranta H. A prospective study of patients with sciatica. Spine. 1990; 15: 1345–1349.
[12] Panagopoulos J, Hush J, Steffens D, Hancock MJ. Do MRI findings change over a period of up to 1 year in patients with low back pain and/or sciatica? A systematic review. Spine. 2017; 42(7): 504–512.
[13] Cook CE, Arnold PM, Passias PG, Frempong-Boadu AK, Radcliff K, Isaacs R. Predictors of pain and disability outcomes in one thousand, one hundred and eight patients who underwent lumbar discectomy surgery. International Orthopaedics. 2015; 39(11): 2143–2151.
[14] Bush K, Cowan N, Katz DE, Gishen P. The natural history of sciatica associated with disc pathology. Spine. 1992; 17(10): 1205–1222; Delauche-Cavalier MC, Budet C, Laredo JD, Debie B, Wybier M, Dorfmann H, Ballner I. Lumbar disc herniation: Computed tomography scan changes after conservative treatment of nerve root compression. Spine. 1992; 17(8): 927–933; Matsubara Y, Kato F, Mimatsu K, Kajino G, Nakamura S, Nitta H. Serial changes on MRI in lumbar disc herniations treated conservatively. Neuroradiology. 1995; 37: 378–383.
[15] Borenstein D. Etiology of low back pain. Family Practice Recertification Management of Chronic Low Back Pain Special Supplement. 1999; 21(7): 6.
[16] Altun I, Yüksel KZ. Lumbar herniated disc: Spontaneous regression. Korean Journal of Pain. 2017; 30(1): 44–50.
[17] Cameron JA, Thielen KM. Autologous platelet rich plasma for neck and lower back pain secondary to spinal disc herniation: Midterm results. Spine Research. 2017 Aug 30; 3(2): Article ID 100030, 5 pages.
[18] Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: An update. International Orthopaedics. 2016; 40(6): 1321–1328.
[19] Tuakli-Wosornu YA. Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, Nguyen JT, Solomon JL, Lutz GE. Lumbar intradiskal platelet-rich plasma (PRP) injections: A prospective, double-blind, randomized controlled study. PM&R. 2016; 8(1): 1–10; Basso M, Cavagnaro L, Zanirato A, Divano S, Formica C, Formica M. What is the clinical evidence on regenerative medicine in intervertebral disc degeneration? Musculoskeletal Surgery. 2017: 1–12.
[20] Lumbar intradiscal platelet rich plasma injections- a multicenter, prospective study in patients with disc disruption; IRB Number: 2015-716. 2016 Aug [2022 March 20] hss.edu/clinical-trials_lumbar-intradiscal-prp-platelet-injections-disc-disruption
[21] Orozco L, Soler R, Morera C, Alberca M, Sánchez A, García-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: A pilot study. Transplantation. 2011; 92(7): 822–828; Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells. 2015; 33(1): 146–156.
[22] Kristin C, Robert S, Michelle P. Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease. Journal of Translational Medicine. 2017; 15:12.
[23] Navani A, Ambach MA, Wei JJ, Gupta D. Biologic therapies for intervertebral degenerative disc disease: A review of novel applications. Journal of Stem Cell Research, Reviews, & Reports. 2017; 4(1): Article ID 1023, 9 pages; Zeckser J, Wolff M, Tucker J, Goodwin J. Multipotent mesenchymal stem cell treatment for discogenic low back pain and disc degeneration. Stem Cells International. 2016: Article ID 3908389, 13 pages.